Suppr超能文献

将 PANSS 和 SAPS/SANS 的阳性和阴性症状评分进行转换。

Converting positive and negative symptom scores between PANSS and SAPS/SANS.

机构信息

Department of Psychiatry and Human Behavior, University of California, Irvine, Irvine, CA 92617, United States.

Mind Research Network, Albuquerque, NM 87106, United States; Departments of Psychiatry & Neuroscience, University of New Mexico, Albuquerque, NM 87131, United States.

出版信息

Schizophr Res. 2014 Jan;152(1):289-94. doi: 10.1016/j.schres.2013.11.013. Epub 2013 Dec 11.

Abstract

The Scale for the Assessment of Positive Symptoms (SAPS), the Scale for the Assessment of Negative Symptoms (SANS), and the Positive and Negative Syndrome Scale for Schizophrenia (PANSS) are the most widely used schizophrenia symptom rating scales, but despite their co-existence for 25 years no easily usable between-scale conversion mechanism exists. The aim of this study was to provide equations for between-scale symptom rating conversions. Two-hundred-and-five schizophrenia patients [mean age±SD=39.5±11.6, 156 males] were assessed with the SANS, SAPS, and PANSS. Pearson's correlations between symptom scores from each of the scales were computed. Linear regression analyses, on data from 176 randomly selected patients, were performed to derive equations for converting ratings between the scales. Intraclass correlations, on data from the remaining 29 patients, not part of the regression analyses, were performed to determine rating conversion accuracy. Between-scale positive and negative symptom ratings were highly correlated. Intraclass correlations between the original positive and negative symptom ratings and those obtained via conversion of alternative ratings using the conversion equations were moderate to high (ICCs=0.65 to 0.91). Regression-based equations may be useful for conversion between schizophrenia symptom severity as measured by the SANS/SAPS and PANSS, though additional validation is warranted. This study's conversion equations, implemented at http:/converteasy.org, may aid in the comparison of medication efficacy studies, in meta- and mega-analyses examining symptoms as moderator variables, and in retrospective combination of symptom data in multi-center data sharing projects that need to pool symptom rating data when such data are obtained using different scales.

摘要

《阳性症状评定量表(SAPS)》《阴性症状评定量表(SANS)》和《精神分裂症阳性和阴性症状量表(PANSS)》是最广泛使用的精神分裂症症状评定量表,但尽管它们共存了 25 年,却没有一个易于使用的量表间转换机制。本研究旨在提供量表间症状评定转换的公式。205 例精神分裂症患者[平均年龄±标准差=39.5±11.6,156 名男性]接受了 SANS、SAPS 和 PANSS 的评估。计算了来自每个量表的症状评分之间的 Pearson 相关系数。对 176 名随机选择的患者的数据进行线性回归分析,得出了在这些量表之间转换评分的公式。对未参与回归分析的 29 名其余患者的数据进行组内相关分析,以确定评分转换的准确性。量表间的阳性和阴性症状评分高度相关。原始阳性和阴性症状评分与使用转换公式转换替代评分获得的评分之间的组内相关系数为中等至高度(ICC=0.65 至 0.91)。基于回归的方程可能有助于 SANS/SAPS 和 PANSS 测量的精神分裂症症状严重程度之间的转换,尽管需要进一步验证。本研究的转换方程,可在 http:/converteasy.org 上实现,可有助于比较药物疗效研究,在作为调节变量的症状的元分析和 mega 分析中,以及在需要汇总症状评分数据的多中心数据共享项目的回顾性组合中,这些项目在使用不同量表时需要汇总症状评分数据。

相似文献

1
Converting positive and negative symptom scores between PANSS and SAPS/SANS.
Schizophr Res. 2014 Jan;152(1):289-94. doi: 10.1016/j.schres.2013.11.013. Epub 2013 Dec 11.
2
A positive take on schizophrenia negative symptom scales: Converting scores between the SANS, NSA and SDS.
Schizophr Res. 2018 Nov;201:113-119. doi: 10.1016/j.schres.2018.06.014. Epub 2018 Jun 20.
3
Converting scores between the PANSS and SAPS/SANS beyond the positive/negative dichotomy.
Psychiatry Res. 2021 Nov;305:114199. doi: 10.1016/j.psychres.2021.114199. Epub 2021 Sep 1.
5
Validity of specific subscales of the positive and negative symptom scales in older schizophrenia outpatients.
Schizophr Res. 1997 Oct 30;27(2-3):219-26. doi: 10.1016/S0920-9964(97)00066-2.
6
Is it possible to combine different psychotic symptom scales in bipolar disorder?
Psychiatry Res. 2014 Dec 30;220(3):1090-3. doi: 10.1016/j.psychres.2014.10.018.
7
Assessment of negative symptoms and depression in schizophrenia: revision of the SANS and how it relates to the PANSS and CDSS.
Schizophr Res. 2011 Mar;126(1-3):226-30. doi: 10.1016/j.schres.2010.09.023. Epub 2010 Nov 5.
8
Symptom assessment in early psychosis: the use of well-established rating scales in clinical high-risk and recent-onset populations.
Psychiatry Res. 2014 Dec 30;220(3):1077-83. doi: 10.1016/j.psychres.2014.07.047. Epub 2014 Aug 1.
9
Choosing negative symptom instruments: issues of representation and redundancy.
Psychiatry Res. 1999 Jul 30;87(1):47-56. doi: 10.1016/s0165-1781(99)00042-6.

引用本文的文献

3
Putative Mechanisms of Electroconvulsive Therapy in Treatment-Resistant Schizophrenia Examined Using Magnetic Resonance Imaging.
Biol Psychiatry Glob Open Sci. 2025 Apr 1;5(4):100494. doi: 10.1016/j.bpsgos.2025.100494. eCollection 2025 Jul.
4
COSMIN systematic review and meta-analysis of the measurement properties of the Positive and Negative Syndrome Scale (PANSS).
EClinicalMedicine. 2025 Apr 11;82:103155. doi: 10.1016/j.eclinm.2025.103155. eCollection 2025 Apr.
5
COSMIN review of the PANSS Marder factor solution and other factor models in people with schizophrenia.
Schizophrenia (Heidelb). 2025 Mar 31;11(1):51. doi: 10.1038/s41537-025-00600-6.
6
Differences in Blood Leukocyte Subpopulations in Schizophrenia: A Systematic Review and Meta-Analysis.
JAMA Psychiatry. 2025 May 1;82(5):492-504. doi: 10.1001/jamapsychiatry.2024.4941.
8
ENIGMA-Meditation: Worldwide Consortium for Neuroscientific Investigations of Meditation Practices.
Biol Psychiatry Cogn Neurosci Neuroimaging. 2025 Apr;10(4):425-436. doi: 10.1016/j.bpsc.2024.10.015. Epub 2024 Nov 6.
9
Theta Burst Stimulation Protocols for Schizophrenia: A Systematic Review and Network Meta-Analysis.
JAMA Netw Open. 2024 Oct 1;7(10):e2441159. doi: 10.1001/jamanetworkopen.2024.41159.
10
Topological abnormalities of the morphometric similarity network of the cerebral cortex in schizophrenia.
Schizophrenia (Heidelb). 2024 Jun 17;10(1):57. doi: 10.1038/s41537-024-00477-x.

本文引用的文献

1
Symptom dimensions and functional impairment in early psychosis: more to the story than just negative symptoms.
Schizophr Res. 2013 Jun;147(1):125-131. doi: 10.1016/j.schres.2013.03.024. Epub 2013 Apr 12.
2
Can we combine symptom scales for collaborative research projects?
J Psychiatr Res. 2012 Feb;46(2):233-8. doi: 10.1016/j.jpsychires.2011.10.002. Epub 2011 Nov 5.
3
Is the PANSS used correctly? a systematic review.
BMC Psychiatry. 2011 Jul 18;11:113. doi: 10.1186/1471-244X-11-113.
4
SPES/SCOPA and MDS-UPDRS: formulas for converting scores of two motor scales in Parkinson's disease.
Parkinsonism Relat Disord. 2011 Sep;17(8):632-4. doi: 10.1016/j.parkreldis.2011.05.022. Epub 2011 Jun 22.
5
Assessment of negative symptoms and depression in schizophrenia: revision of the SANS and how it relates to the PANSS and CDSS.
Schizophr Res. 2011 Mar;126(1-3):226-30. doi: 10.1016/j.schres.2010.09.023. Epub 2010 Nov 5.
6
The PANSS should be rescaled.
Schizophr Bull. 2010 May;36(3):461-2. doi: 10.1093/schbul/sbq016. Epub 2010 Mar 31.
7
Should the PANSS be rescaled?
Schizophr Bull. 2010 May;36(3):455-60. doi: 10.1093/schbul/sbp124. Epub 2009 Nov 4.
8
Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: a meta-analysis.
Schizophr Res. 2009 Sep;113(2-3):189-99. doi: 10.1016/j.schres.2009.03.035. Epub 2009 Jul 22.
9
Definitions of response and remission in schizophrenia: recommendations for their use and their presentation.
Acta Psychiatr Scand Suppl. 2009(438):7-14. doi: 10.1111/j.1600-0447.2008.01308.x.
10
Symptom rating scales and outcome in schizophrenia.
Br J Psychiatry Suppl. 2007 Aug;50:s7-14. doi: 10.1192/bjp.191.50.s7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验